Jasper Therapeutics CFO Herb Cross resigns effective Oct. 9
JSPR•Jasper Therapeutics CFO Herb Cross resigned effective Oct. 9 to pursue other professional opportunities, and the company named interim replacements for three roles.
1. Interim appointments
CEO Jeet Mahal was named interim principal financial officer effective with Cross’ departure. Vice President of Finance Rick Ruiz was appointed interim principal accounting officer, and Chief Operating Officer Matthew Ros was named interim corporate secretary, both effective Oct. 9. Ruiz joined in 2024 and has more than 25 years of experience in accounting, FP&A, financing and SEC reporting.
